Document Detail


Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: Does timing matter?
MedLine Citation:
PMID:  20685164     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
PURPOSE: The aim of this study was to examine how patients recall symptoms at a delayed self-report. Accurate insight into toxicity symptoms during chemotherapy is essential so that nurses and doctors can assess therapeutic tolerance and adjust supportive care accordingly.
METHOD: A non-experimental, longitudinal design was employed. Using the Therapy-Related Symptoms Checklist (TRSC), respondents (n = 142) reported their initial symptoms during the first 7 days of the chemotherapy cycle at two different times: (1) each day of the first seven days after the chemotherapy administration (immediate self-report), and (2) at their next hospital visit for chemotherapy (delayed self-report). We compared the number and severity of symptoms and side effects reported in the immediate and delayed self-reports.
RESULTS: Respondents reported significantly fewer symptoms and fewer severe symptoms in the delayed self-report. For 22 out of 25 symptoms the delayed-reported grade was significantly lower than the immediate-reported maximum grade. Compared to the immediate-reported median grade, significant differences occurred in only 10 out of the 25 symptoms. In all cases, except fatigue, the delayed-reported grade was significantly higher than the immediate-reported median grade.
CONCLUSIONS: This study indicates that delayed self-report of chemotherapy side effects is not an appropriate measure of actual symptoms and side effects experienced by patients. Delayed self-report gives a weaker insight into actual symptom burden. Fatigue is at particular risk to be minimized at the delayed self-report. Therefore it is recommended to assess chemotherapy-related symptoms and side effects by means of immediate self-report.
Authors:
Annemarie Coolbrandt; Koen Van den Heede; Ellen Vanhove; Ann De Bom; Koen Milisen; Hans Wildiers
Related Documents :
8811274 - Photophobia and lithium.
18000964 - Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review ...
19755624 - Evidence-based treatment options for the management of skin toxicities associated with ...
24255844 - Inguinal ovary in adult women-case report and literature review.
2670704 - Chronic peroneal tendon subluxation produced by an anomalous peroneus brevis: case repo...
968694 - Computerised axial tomography of the head.
Publication Detail:
Type:  Journal Article     Date:  2010-08-03
Journal Detail:
Title:  European journal of oncology nursing : the official journal of European Oncology Nursing Society     Volume:  15     ISSN:  1532-2122     ISO Abbreviation:  Eur J Oncol Nurs     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100885136     Medline TA:  Eur J Oncol Nurs     Country:  Scotland    
Other Details:
Languages:  eng     Pagination:  130-6     Citation Subset:  IM; N    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Department of Oncology/Hematology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence.
Next Document:  Therapeutic applications of ribozymes and riboswitches.